Physician profile
Robert Lawrence Schiff
NPI 1235234378
$2,048.45
in general payments reported to CMS, 2019-2025
18 companies · $83.48 in 2025
The $83.48 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $392 · 2020: $237 · 2021: $476 · 2022: $348 · 2023: $250 · 2024: $262 · 2025: $83.48.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $596.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $595.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $652.67 | 2019-2024 | Ozempic, Rybelsus, Wegovy |
| Amarin Pharma, INC. | $350.42 | 2019-2022 | |
| Lilly USA, LLC | $203.83 | 2021-2025 | Mounjaro, Zepbound, Trulicity |
| Astrazeneca Pharmaceuticals LP | $189.01 | 2019-2024 | Breztri |
| Astellas Pharma US INC | $150.43 | 2020-2023 | Myrbetriq |
| Amgen INC. | $135.53 | 2023-2025 | Otezla, Repatha, Otezla |
| Novartis Pharmaceuticals Corporation | $116.84 | 2022-2023 | |
| Boston Scientific Corporation | $40.37 | 2019 | |
| Inspire Medical Systems, INC. | $32.28 | 2025 | Inspire |
| Radius Health, INC. | $30.10 | 2019 | |
| Abbvie INC. | $26.18 | 2021 | |
| Janssen Pharmaceuticals, INC | $20.85 | 2019 | |
| Neurocrine Biosciences, INC. | $19.92 | 2021 | |
| Glaxosmithkline, LLC. | $19.56 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $18.53 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $15.08 | 2019 | |
| Horizon Therapeutics Plc | $13.95 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $12.90 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Schiff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.